The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on April 17, 2026

Apr. 17, 2026

Abe Safa Expands Market Presence Across Myrtle Beach Real Estate Market

Indeterminate GlobeNewswire

Apr. 17, 2026

Grupo Aeroportuario del Pacifico Announces Filing of 2025 Annual Report and Form 20-F

Indeterminate GlobeNewswire

Apr. 17, 2026

Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire

Apr. 17, 2026

Rocket Doctor Amends 45 Degree Agreement

Indeterminate GlobeNewswire

Apr. 17, 2026

Notice of 2026 First Quarter Results Conference Call and Webcast for Investors and Analysts and Annual Meeting of Shareholders

Indeterminate GlobeNewswire

Apr. 17, 2026

Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC

Indeterminate GlobeNewswire

Apr. 17, 2026

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call

Indeterminate GlobeNewswire

Apr. 17, 2026

BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026

Indeterminate GlobeNewswire

Apr. 17, 2026

Quantify Funds to Close STKd 100% NVDA & 100% AMD ETF (LAYS)

Indeterminate GlobeNewswire

Apr. 17, 2026

Sonoco To Report First Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 17, 2026

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

Indeterminate GlobeNewswire

Apr. 17, 2026

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

Indeterminate GlobeNewswire

Apr. 17, 2026

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities

Indeterminate GlobeNewswire

Apr. 17, 2026

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Indeterminate GlobeNewswire

Apr. 17, 2026

Action Target Announces Registration Is Open for 34th Annual Law Enforcement Training Camp (LETC)

Indeterminate GlobeNewswire